Canadian Cohort of Convective Thermal Therapy Using Rezūm System in Benign Prostatic Hyperplasia (BPH).
ConditionUrologic Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorCan-Am HIFU Inc.
About this trial
To document the clinical outcome of Rezūm therapy for BPH patient in Canadian cohort.
Eligibility criteria
Qualifiers
Male subjects of ≥ 18 years of age.
Primary diagnosis of Benign Prostate Hypertrophy (BPH).
Candidate for Rezūm therapy as per clinical decision of Investigator.
Willing and able to accurately complete the required questionnaires.
Disqualifiers
Characteristics indicating a poor compliance with study protocol requirements.
Disease or other health condition that is not suitable for this study.
Unable or unwilling to provide signed informed consent.
Trial design
Treatments tested in this trial
- Rezum
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov